progestin receptors
Recently Published Documents


TOTAL DOCUMENTS

247
(FIVE YEARS 2)

H-INDEX

42
(FIVE YEARS 0)

2021 ◽  
Vol 134 ◽  
pp. 105012
Author(s):  
Jonathan J. Carver ◽  
Skyler C. Carrell ◽  
Matthew W. Chilton ◽  
Julia N. Brown ◽  
Lengxob Yong ◽  
...  


2021 ◽  
Vol 11 ◽  
Author(s):  
Cheryl A. Frye ◽  
Vincent F. Lembo ◽  
Alicia A. Walf

Progestogens' (e.g., progesterone and its neuroactive metabolite, allopregnanolone), cognitive effects and mechanisms among males are not well-understood. We hypothesized if progestogen's effects on cognitive performance are through its metabolite allopregnanolone, and not actions via binding to traditional progestin receptors (PRs), then progesterone administration would enhance performance in tasks mediated by the hippocampus and cortex, coincident with increasing allopregnanolone concentrations, brain derived neurotrophic factor (BDNF) and/or muscimol binding of PR knock out (PRKO) and wild-type PR replete mice. Experiment 1: Progesterone (4 mg/kg, subcutaneously (SC; n = 12/grp), or oil vehicle control, was administered to gonadally-intact adult male mice PRKO mice and their wild-type counterparts and cognitive behaviors in object recognition, T-maze and water maze was examined. Progesterone, compared to vehicle, when administered post-training increased time investigating novel objects by the PRKO and wild-type mice in the object recognition task. In the T-maze task, progesterone administration to wild-type and PRKO mice had significantly greater number of spontaneous alternations compared to their vehicle-administered counterparts. In the water maze task, PRKO mice administered vehicle spent significantly fewer seconds in the quadrant associated with the escape platform on testing compared to all other groups. Experiment 2: Progesterone administered to wild-type and PRKO mice increased plasma progesterone and allopregnanolone levels (n = 5/group). PRKO mice had higher allopregnanolone levels in plasma and hippocampus, but not cortex, when administered progesterone and compared to wild-type mice. Experiment 3: Assessment of PR binding revealed progesterone administered wild-type mice had significantly greater levels of PRs in the hippocampus and cortex, compared to all other groups (n = 5/group). Wild-type mice administered progesterone, but not vehicle, had increased BDNF levels in the hippocampus, but not the cortex, compared to PRKOs. Wild-type as well as PRKO mice administered progesterone experienced significant increases in maximal GABAA agonist, muscimol, binding in hippocampus and cortex, compared to their vehicle-administered counterparts. Thus, adult male mice can be responsive to progesterone for cognitive performance, and such effects may be independent of PRs trophic actions of BDNF levels in the hippocampus and/or increases in GABAA activity in the hippocampus and cortex.



2020 ◽  
Vol 74 ◽  
pp. 601-609
Author(s):  
Susan Afshari-Stasiak ◽  
Jacek Wilczyński ◽  
Maria Szubert

SEO – synchronous endometrial ovarian cancer is a well-known phenomenon, which has for years been managed as two primary independent cancers. The results of recent molecular studies, especially next-generation sequencing, suggest that the condition should be regarded as a continuum, with its origin probably lying in the endometrium or endometrial foci. It has been found that 0.7% to 1.0% of endometriosis patients may develop malignant lesions. Although SEO is being increasingly studied, diagnostics and treatment still leave many questions. The most important thing is to improve the diagnosis with rapid and simple detection. A few molecular methods are already known, but genetic diagnostic, still remains unclear. Old criteria implemented by Scully in 1998 should be nowadays complemented by immunohistochemical staining of estrogen and progestin receptors, bcl2 antibodies and molecular analyses of genes: B-catenin, PTEN, KRAS, TP53, PIK3CA and microsatellite instability. Will genetic diagnostics preserve fertility in young patients with SEO? This paper reviews relevant literature to determine a strategy for distinguishing between SEO and metastatic cancers, and presents management options for patients with SEO.



2019 ◽  
Vol 140 ◽  
pp. 171-179 ◽  
Author(s):  
Magdalena K. Kowalik ◽  
Karolina Dobrzyn ◽  
Robert Rekawiecki ◽  
Jan Kotwica


Author(s):  
Marina Morini ◽  
David S. Peñaranda ◽  
María C. Vílchez ◽  
Rasoul Nourizadeh-Lillabadi ◽  
Anne-Gaëlle Lafont ◽  
...  


2016 ◽  
Vol 77 (6) ◽  
pp. 767-774 ◽  
Author(s):  
Christine K. Wagner ◽  
Princy Quadros-Mennella


Sign in / Sign up

Export Citation Format

Share Document